These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22199120)

  • 1. Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I.
    Frantz S; Klaiber M; Baba HA; Oberwinkler H; Völker K; Gaβner B; Bayer B; Abeβer M; Schuh K; Feil R; Hofmann F; Kuhn M
    Eur Heart J; 2013 Apr; 34(16):1233-44. PubMed ID: 22199120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.
    Klaiber M; Kruse M; Völker K; Schröter J; Feil R; Freichel M; Gerling A; Feil S; Dietrich A; Londoño JE; Baba HA; Abramowitz J; Birnbaumer L; Penninger JM; Pongs O; Kuhn M
    Basic Res Cardiol; 2010 Sep; 105(5):583-95. PubMed ID: 20352235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis.
    Patrucco E; Domes K; Sbroggió M; Blaich A; Schlossmann J; Desch M; Rybalkin SD; Beavo JA; Lukowski R; Hofmann F
    Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12925-9. PubMed ID: 25139994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide-mediated inhibition of microcirculatory endothelial Ca2+ and permeability response to histamine involves cGMP-dependent protein kinase I and TRPC6 channels.
    Chen W; Oberwinkler H; Werner F; Gaßner B; Nakagawa H; Feil R; Hofmann F; Schlossmann J; Dietrich A; Gudermann T; Nishida M; Del Galdo S; Wieland T; Kuhn M
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2121-9. PubMed ID: 23814119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased effects of C-type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP-dependent protein kinase I.
    Wollert KC; Yurukova S; Kilic A; Begrow F; Fiedler B; Gambaryan S; Walter U; Lohmann SM; Kuhn M
    Br J Pharmacol; 2003 Dec; 140(7):1227-36. PubMed ID: 14609817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of phospholamban in cyclic GMP mediated signaling in cardiac myocytes.
    Zhang Q; Scholz PM; Pilzak A; Su J; Weiss HR
    Cell Physiol Biochem; 2007; 20(1-4):157-66. PubMed ID: 17595525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CaMKII-mediated increased lusitropic responses to beta-adrenoreceptor stimulation in ANP-receptor deficient mice.
    Yurukova S; Kilić A; Völker K; Leineweber K; Dybkova N; Maier LS; Brodde OE; Kuhn M
    Cardiovasc Res; 2007 Mar; 73(4):678-88. PubMed ID: 17107670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac hypertrophy is not amplified by deletion of cGMP-dependent protein kinase I in cardiomyocytes.
    Lukowski R; Rybalkin SD; Loga F; Leiss V; Beavo JA; Hofmann F
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5646-51. PubMed ID: 20212138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice.
    Pierkes M; Gambaryan S; Bokník P; Lohmann SM; Schmitz W; Potthast R; Holtwick R; Kuhn M
    Cardiovasc Res; 2002 Mar; 53(4):852-61. PubMed ID: 11922895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
    Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
    Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
    Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
    J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SERCA2 activity is involved in the CNP-mediated functional responses in failing rat myocardium.
    Moltzau LR; Aronsen JM; Meier S; Nguyen CH; Hougen K; Ørstavik Ø; Sjaastad I; Christensen G; Skomedal T; Osnes JB; Levy FO; Qvigstad E
    Br J Pharmacol; 2013 Sep; 170(2):366-79. PubMed ID: 23808942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness.
    Michel K; Herwig M; Werner F; Špiranec Spes K; Abeßer M; Schuh K; Dabral S; Mügge A; Baba HA; Skryabin BV; Hamdani N; Kuhn M
    JCI Insight; 2020 Nov; 5(22):. PubMed ID: 33055420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contractile Function During Angiotensin-II Activation: Increased Nox2 Activity Modulates Cardiac Calcium Handling via Phospholamban Phosphorylation.
    Zhang M; Prosser BL; Bamboye MA; Gondim ANS; Santos CX; Martin D; Ghigo A; Perino A; Brewer AC; Ward CW; Hirsch E; Lederer WJ; Shah AM
    J Am Coll Cardiol; 2015 Jul; 66(3):261-272. PubMed ID: 26184620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cGMP/cGKI signalling and Trpc channels in regulation of vascular tone.
    Loga F; Domes K; Freichel M; Flockerzi V; Dietrich A; Birnbaumer L; Hofmann F; Wegener JW
    Cardiovasc Res; 2013 Nov; 100(2):280-7. PubMed ID: 23832809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.
    Miller CL; Oikawa M; Cai Y; Wojtovich AP; Nagel DJ; Xu X; Xu H; Florio V; Rybalkin SD; Beavo JA; Chen YF; Li JD; Blaxall BC; Abe J; Yan C
    Circ Res; 2009 Nov; 105(10):956-64. PubMed ID: 19797176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
    Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
    Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-Nitrosylation of Calcium-Handling Proteins in Cardiac Adrenergic Signaling and Hypertrophy.
    Irie T; Sips PY; Kai S; Kida K; Ikeda K; Hirai S; Moazzami K; Jiramongkolchai P; Bloch DB; Doulias PT; Armoundas AA; Kaneki M; Ischiropoulos H; Kranias E; Bloch KD; Stamler JS; Ichinose F
    Circ Res; 2015 Oct; 117(9):793-803. PubMed ID: 26259881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.
    Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
    Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyocyte PKA Ablation Enhances Basal Contractility While Eliminates Cardiac β-Adrenergic Response Without Adverse Effects on the Heart.
    Zhang Y; Wang WE; Zhang X; Li Y; Chen B; Liu C; Ai X; Zhang X; Tian Y; Zhang C; Tang M; Szeto C; Hua X; Xie M; Zeng C; Wu Y; Zhou L; Zhu W; Yu D; Houser SR; Chen X
    Circ Res; 2019 Jun; 124(12):1760-1777. PubMed ID: 30982412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.